amyloid-beta peptide in plasma
Jump to navigation
Jump to search
Indications
- proposed as a screening test for Alzheimer's disease*
* plasma levels predict beta-amyloid in CSF?
Methods
- liquid chromatography with mass spectrometry detection[2]
More general terms
More specific terms
Additional terms
References
- ↑ Nakamura A, Kaneko N, Villemagne VL et al High performance plasma amyloid-beta biomarkers for Alzheimer's disease. Nature. 2018 Feb 8;554(7691):249-254 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29420472 https://www.nature.com/articles/nature25456
- ↑ 2.0 2.1 Keshavan A, Pannee J, Karikari TK et al Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70. Brain 2021. Jan 22 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33479777 https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awaa403/6105867